Sv Life Sciences Fund Iv Strategic Partners, L. P. - Net Worth and Insider Trading

Sv Life Sciences Fund Iv Strategic Partners, L. P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sv Life Sciences Fund Iv Strategic Partners, L. P. owns 6 companies in total, including KalVista Pharmaceuticals Inc (KALV) , Entellus Medical Inc (ENTL) , and Ocular Therapeutix Inc (OCUL) among others .

Click here to see the complete history of Sv Life Sciences Fund Iv Strategic Partners, L. P.’s form 4 insider trades.

Insider Ownership Summary of Sv Life Sciences Fund Iv Strategic Partners, L. P.

Ticker Company Transaction Date Type of Owner
KALV KalVista Pharmaceuticals Inc 2018-12-19 10 percent owner
ENTL Entellus Medical Inc 2017-01-31 10 percent owner
OCUL Ocular Therapeutix Inc 2014-07-24 10 percent owner
LIMIT LIMIT 2013-09-24 10 percent owner
LIMIT LIMIT 2013-09-03 10 percent owner
LIMIT LIMIT 2010-05-03 10 percent owner

Sv Life Sciences Fund Iv Strategic Partners, L. P. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sv Life Sciences Fund Iv Strategic Partners, L. P. Ownership Network

Ownership Network List of Sv Life Sciences Fund Iv Strategic Partners, L. P.

No Data

Ownership Network Relation of Sv Life Sciences Fund Iv Strategic Partners, L. P.

Insider Network Chart


Sv Life Sciences Fund Iv Strategic Partners, L. P. Owned Company Details

What does KalVista Pharmaceuticals Inc do?

Who are the key executives at KalVista Pharmaceuticals Inc?

Sv Life Sciences Fund Iv Strategic Partners, L. P. is the 10 percent owner of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include CFO and Secretary Benjamin L Palleiko , Chief Medical Officer Paul K. Audhya , and Chief Development Officer Christopher Yea .

KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary

Over the past 18 months, Sv Life Sciences Fund Iv Strategic Partners, L. P. made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,612,229 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 169,424 shares made by Benjamin L Palleiko , and a net sale of 93,084 shares made by Christopher Yea .

In summary, during the past 3 months, insiders sold 35,430 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 25,000 shares, with a net sale of 10,430 shares. During the past 18 months, 551,271 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,612,229 shares were bought by its insiders, resulting in a net purchase of 1,060,958 shares.

KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

KalVista Pharmaceuticals Inc Insider Transactions

No Available Data

Sv Life Sciences Fund Iv Strategic Partners, L. P. Mailing Address

Above is the net worth, insider trading, and ownership report for Sv Life Sciences Fund Iv Strategic Partners, L. P.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Sv Life Sciences Fund Iv Strategic Partners, L. P.'s mailing address is: Boston Ma 02108.